Fidelio/Figaro

Fidelio/Figaro

Purpose: to investigate the effectiveness and safety of finerenone, a blood pressure medicine, in patients with type 2 diabetes and diabetic kidney disease

Inclusion

  • Men or women diagnosed with Type 2 Diabetes
  • Must be at least 18 years old
  • Diagnosed with diabetic kidney disease
  • Stable treatment of blood pressure with ACE-inhibitors (Enalapril, Lisinopril, Quinapril, etc.) or ARBs (Losartan, Valsartan, etc.)

Exclusion

  • Severe uncontrolled hypertension
  • HbA1c > 12%
  • Renal transplant or scheduled within the next 12 months
  • Dialysis for acute renal failure within the past 12 weeks

 

If interested, please contact:

Katarina Vukojicic / Jamie Diner

984-974-3008 / 984-974-3017

Katarina_vukojicic@med.unc.edu / diner@med.unc.edu

 

If you join Fidelio/Figaro, you will receive all medications and supplies at no cost to you.